Access all of the content
We were delighted to have the opportunity to speak with Dr Alba Grifoni ( La Jolla Institute for Immunology, La Jolla, CA, USA) to discuss T Cell responses of SARS-CoV-2 epitopes in COVID-19 cases.
Her abstract entitled: ‘B & T cell interactions: New studies on COVID-19’ (SY08.05) was presented at the HIVR4P Virtual Conference 2021, 04 February 2021.
- What is already known about SARS-CoV-2-specific T cell responses and their impact on disease severity? (0:18)
- Could you give us a brief overview of the aims and design of your study? (1:48)
- How will the study data be used to enhance our understanding of immune responses to SARS-CoV-2 infection? (5:10)
- What gaps remain in our knowledge and what future studies are planned? (6:36)
Disclosures: Alba Grifoni has nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of the HIVR4P 2021 Virtual Meeting.
Share this Video
Related Videos In COVID-19
Paul Heath: Novavax Phase 3 Program of Clinical trials evaluating NVX-CoV2373 across the US, South Africa and UK [Part 2]
It was a great pleasure to meet with Prof. Paul Heath (St George’s, University of London, London, UK) to discuss the findings from the Novavax program of clinical trials evaluating the safety and efficacy of NVX-CoV2373 across the US, South Africa and the UK. Please find Part 1 of this interview available here. To access […]
Paul Heath: Phase 3 trial of Novavax Investigational COVID-19 vaccine [Part 1]
It was a great pleasure to meet with Prof. Paul Heath (St George’s, University of London, London, UK) to discuss the findings from the Phase III Novavax clinical trial that is investigating the safety and efficacy of NVX-CoV2373, a vaccine candidate for COVID-19. Please find Part 2 of this interview available here. To access more […]
Jeffrey Strich: Phase 2 Trial Results Investigating Fostamatinib for the treatment of COVID-19
It was a great pleasure to meet with Jeffrey Strich (National Institutes of Health Clinical Center, Bethesda, MD, USA) to discuss the findings from a recent phase 2 study investigating fostamatinib for the treatment of hospitalized adults with COVID-19. Useful Resources: Published data available here: Fostamatinib for the treatment of hospitalized adults with COVID-19 A […]
Journal articles and more to your inbox
Get the latest clinical insights from touchINFECTIOUS DISEASESSign me up!